Lung Nodule Detection Using Ultra-long FOV PET/CT

Abroad (travel likely)RecruitingPHASE4

Conditions

Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Medical Center Groningen, Groningen, Netherlands
Contact: Study coordinator (Adrienne H Brouwers, MD) · a.h.brouwers@umcg.nl · +31625650037
Contact: Study coordinator (Joyce van Sluis, MSc.) · j.van.sluis@umcg.nl · +31653464058

Study leads

Adrienne H Brouwers, MD PhD
Principal Investigator
Nuclear Medicine physician

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Non-small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Burbank, United States

Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors

Non-Small Cell Lung Cancer · Small Cell Lung Cancer · Extrapulmonary Small Cell Cancer

Abroad (travel likely)Recruiting

Bethesda, United States

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma · Stage IIB Lung Cancer AJCC v8 · Stage III Lung Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Birmingham, United States

Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE3

Shanghai, China · Hangzhou, China